NCT05919537
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05919537
Title Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hummingbird Bioscience
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare North Shore Sydney New South Wales 2065 Australia Details
ICON Cancer Centre South Brisbane Brisbane Queensland 4101 Australia Details
Southern Oncology Clinical Research Unit Adelaide South Australia 5042 Australia Details
Cabrini Health Malvern Victoria 3144 Australia Details
Linear Clinical Research Perth Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field